Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.610
-0.070 (-2.61%)
Feb 20, 2026, 3:05 PM EST - Market open
Genelux Revenue
In the year 2024, Genelux had annual revenue of $8.00K, down -95.29%.
Revenue (ttm)
$8.00K
Revenue Growth
-95.29%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
24
Market Cap
115.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.00K | -162.00K | -95.29% |
| Dec 31, 2023 | 170.00K | -10.90M | -98.46% |
| Dec 31, 2022 | 11.07M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 127.63M |
| Fortress Biotech | 62.30M |
| Codexis | 52.93M |
| Seer, Inc. | 16.38M |
| Korro Bio | 7.37M |
| Coya Therapeutics | 3.99M |
| Cardiff Oncology | 501.00K |
| Inovio Pharmaceuticals | 182.34K |
GNLX News
- 5 weeks ago - Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners - GlobeNewsWire
- 6 weeks ago - Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 6 weeks ago - Genelux Corporation Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - GlobeNewsWire
- 3 months ago - Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 7 months ago - Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 8 months ago - Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - GlobeNewsWire
- 10 months ago - Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire